PotisEdge Secures Fifth Consecutive BNEF Tier 1 Ranking in Q3 2025
VANCOUVER, BC, Aug. 1, 2025 /PRNewswire/ -- Bloomberg New Energy Finance (BNEF),…
Oncotelic Therapeutics Highlights PeerReviewed Publication Linking TGFB2 to Survival in Younger Pancreatic Cancer Patients
Data support further evaluation of investigational antisense OT‑101 (trabedersen) as a TGFB2‑targeted…
AV-Comparatives Validates Real-World Threat Detection in 2025 EDR XDR MDR Certification Testing
INNSBRUCK, Austria, June 15, 2025 /PRNewswire/ -- "As cyberattacks evolve, detection can't…